Rahul Mistry

Chief Executive Officer, Co-Founder

Rahul Mistry CEO GlobalSubmit

Rahul Mistry, CEO and Co-Founder of GlobalSubmit,  is a veteran of the software industry. Mr. Mistry has two decades experience working in the technology product and services field. He was instrumental in the development of the eCTD REVIEW™ and VALIDATE™ software now used exclusively by the U.S. Food & Drug Administration to assess the technical integrity of each drug application the FDA receives.


Connect with Rahul on LinkedIn


As CEO of GlobalSubmit, he has pursued a hands-on approach to working with large, multi-national companies, as well as life science start-ups, to promote the adoption of eCTD submissions. Since co-founding GlobalSubmit in 2004, he has assumed a leadership role not only within the company, but in the industry as well.

Mr. Mistry has led eCTD seminars, participated in industry meetings, and remains well-informed on the state of the industry.

Under Mr. Mistry’s direction, GlobalSubmit continues to innovate and revolutionize the regulatory industry both with software and processes. GlobalSubmit now offers a comprehensive submission publishing suite, PUBLISH, and will soon be releasing a DMS and RIMS solution to meet the industry’s technology needs. GlobalSubmit’s Agile for Regulatory Submissions process is the first of its kind in the industry, and has a 75% early submission rate.

Mr. Mistry holds a bachelor’s degree in Social Psychology from Princeton University, where he was a member of the Tigers championship varsity football team.

Articles and Presentations

Japan and eCTD: What We Know, eCTD Summit, March 29, 2016

eCTD Adoption Among Major Reforms Underway in China Pharmaceutical Market, eCTD Summit, January 21, 2016

GlobalSubmit Responds to CSC, LinkedIn, August 27, 2015

Drug Development Costs Continue to Rise, eCTD Summit, February 6, 2013

Simultaneous Submission to Multiple Regions, eCTD Summit, January 7, 2013